{
  "ptid_time": "053_S_5287_2013-09-10",
  "img_path": "/data/qiuhui/data/adni/images/053_S_5287/2013-09-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,538 mm³, 55.1% above the reference mean. With a Z-score of 1.26 (89.7th percentile), this represents mild enlargement; hippocampal volume measures 7,388 mm³, 3.8% above the reference mean. With a Z-score of 0.35 (63.8th percentile), this represents normal volume ; whole brain volume measures 971,226 mm³, 0.4% below the reference mean. With a Z-score of -0.04 (48.2th percentile), this represents normal volume ; entorhinal cortex volume measures 3,518 mm³, 4.2% below the reference mean. With a Z-score of -0.26 (39.8th percentile), this represents normal volume ; fusiform gyrus volume measures 14,266 mm³, 16.1% below the reference mean. With a Z-score of -1.47 (7.1th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,363 mm³, 9.4% below the reference mean. With a Z-score of -0.82 (20.7th percentile), this represents normal volume . ",
  "text_data": "Age is 78.9 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Musculoskeletal; Allergies or Drug Sensitivities; Smoking; Malignancy; Major Surgical Procedures. MMSE: 29.0. MoCA: 28.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.22 SUVR (mild elevated); Total tau: 268.40 pg/mL (normal ); Phosphorylated tau: 26.11 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging shows mild ventricular enlargement (Z-score 1.26) and mild fusiform gyrus atrophy (Z-score -1.47), but hippocampal and entorhinal cortex volumes are within normal ranges. Cognitive scores (MMSE 29, MoCA 28) are intact, and biomarkers (normal tau, mild AV45 elevation) suggest early amyloid pathology without significant neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are preserved, but fusiform atrophy and mild amyloid elevation raise suspicion for early MCI. Lack of significant hippocampal atrophy or clinical symptoms limits confidence.)  \n\n**Key Points:**  \n- Fusiform gyrus atrophy (7th percentile) is concerning but isolated.  \n- Normal hippocampal/entorhinal volumes and high cognitive scores argue against dementia.  \n- Mild amyloid elevation (AV45) supports preclinical/prodromal Alzheimer’s changes.  \n- APOE4-negative status reduces risk severity.  \n\n**Note:** Monitor for subtle cognitive decline (e.g., visual memory/naming deficits from fusiform involvement) and repeat imaging/biomarkers if symptoms emerge.",
  "timestamp": "2025-07-26T08:02:16.422373"
}